Search

Your search keyword '"Rett, K"' showing total 289 results

Search Constraints

Start Over You searched for: Author "Rett, K" Remove constraint Author: "Rett, K"
289 results on '"Rett, K"'

Search Results

101. Obesity and metabolic surgery in type 1 diabetes mellitus.

102. [Cost saving program instead of optimizing therapy: disease mismanagement in diabetes mellitus? (interview by Dr. med. Jochen Aumiller)].

103. Reduced skeletal muscle oxygen uptake and reduced beta-cell function: two early abnormalities in normal glucose-tolerant offspring of patients with type 2 diabetes.

104. Acute effect of glimepiride on insulin-stimulated glucose metabolism in glucose-tolerant insulin-resistant offspring of patients with type 2 diabetes.

105. Troglitazone downregulates delta-6 desaturase gene expression in human skeletal muscle cell cultures.

106. Flow associated (endothelium dependent) vasodilation and TSH-levels in young normotensive and normoglycemic subjects.

107. Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells.

108. Type I hyperlipoproteinemia due to a novel loss of function mutation of lipoprotein lipase, Cys(239)-->Trp, associated with recurrent severe pancreatitis.

109. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance.

110. The silent PPARgamma exon 6 CAC(His) --> CAT(His) polymorphism does not affect the plasma leptin levels in a collective of first degree relatives of type 2 diabetes patients from South West Germany.

111. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy.

112. Beta-blocking agents in patients with insulin resistance: effects of vasodilating beta-blockers.

113. Antihypertensive therapy and insulin sensitivity: do we have to redefine the role of beta-blocking agents?

114. Perfusion-independent effect of bradykinin and fosinoprilate on glucose transport in Langendorff rat hearts.

115. [Impaired glucose tolerance].

116. [Newly manifested type IIb diabetes presents with significant hyperinsulinemia].

117. Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study.

118. Insulin-induced glucose transporter (GLUT1 and GLUT4) translocation in cardiac muscle tissue is mimicked by bradykinin.

119. Potential role of bradykinin in forearm muscle metabolism in humans.

120. Hypertension in the non-insulin-dependent diabetes mellitus syndrome: a critical review of therapeutic intervention.

121. [How can primary prevention of coronary heart disease be improved in general practice?].

122. Insulin-induced translocation of GLUT 4 in skeletal muscle of insulin-resistant Zucker rats.

123. [The metabolic syndrome. Pathophysiologic causes, diagnosis, therapy].

125. [Hypertension in metabolic syndrome. Etiology and consequences].

126. Normal insulin receptor tyrosine kinase activity and glucose transporter (GLUT 4) levels in the skeletal muscle of hyperinsulinaemic hypertensive rats.

127. Changes of hepatic morphology during parenteral nutrition with lipid emulsions containing LCT or MCT/LCT quantified by ultrasound.

129. [Effect of prostaglandin E1 on amino acid metabolism of human skeletal muscle].

130. [Essential hypertension and diabetes mellitus].

131. [ACE-inhibitors and glucose metabolism].

132. Effects of beta-blocking agents on insulin secretion and glucose disposal.

133. The effects of bradykinin and the ischemic isolated rat heart.

134. [Hyperinsulinemia. Current thinking on cardiovascular risks].

135. Clinical studies with CE-inhibitors in diabetes.

136. Local generation of kinins in working skeletal muscle tissue in man.

137. Role of angiotensin-converting enzyme inhibitors in early antihypertensive treatment in non-insulin dependent diabetes mellitus.

139. Dose-dependent effect of bradykinin on muscular blood flow and glucose uptake in man.

140. The kallikrein/kinin system in the pathogenesis of hypertension in diabetes mellitus.

141. Improvement of impaired postoperative insulin action by bradykinin.

142. Increased insulin-responsiveness by ACE-inhibition in noninsulin dependent diabetes mellitus.

143. Metabolic effects of prostaglandin E1 on human skeletal muscle with special regard to the amino acid metabolism.

144. [Effect of fructose and sorbitol on insulin-induced hypoglycemia].

145. [Comparative studies of the metabolism of MCT/LCT and LCT emulsions in diabetics].

146. Angiotensin converting enzyme inhibitors in diabetes: experimental and human experience.

147. [Postreceptor defect in the effectiveness of insulin: significance of the kallikrein-kinin-prostaglandin system].

148. [Inhibition of muscle amino acid release by infusion of a triglyceride emulsion].

149. [The method of the isolated perfused rat heart using the Langendorff model in nutrition research].

150. [Artificial nutrition of diabetic patients].

Catalog

Books, media, physical & digital resources